NeoGenomics offers a suite of LDT-validated targeted clinical assays for hematological malignancies. These assays go beyond cells identification, delivering detailed prognostic insights into malignant cell populations.
- Highly controlled and standardized staining and acquisition procedures
- Data analysis by trained and licensed clinical laboratory scientists
- Review by board-certified hematopathologists
CTA style
Default